Cimzia 200 mg/mL
certolizumab pegol · INJECTION, SOLUTION · UCB, Inc.
Cimzia is a injection, solution containing certolizumab pegol at 200 mg/mL, taken subcutaneous. Manufactured by UCB, Inc..
Key Facts
- Brand Name
- Cimzia
- Generic Name
- certolizumab pegol
- NDC Code (Product)
50474-710- Manufacturer
- UCB, Inc.
- Strength
- 200 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA125160
- Drug Class
- Tumor Necrosis Factor Blocker [EPC]
- Marketing Start
- 05/14/2009
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Frequently Asked Questions
What is Cimzia used for?
Cimzia contains certolizumab pegol. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is Cimzia a controlled substance?
Cimzia is not classified as a controlled substance by the DEA.
What is the generic name for Cimzia?
The generic name for Cimzia is certolizumab pegol. There are no other listed brand versions of certolizumab pegol.
What is the NDC code for Cimzia 200 mg/mL?
The NDC (National Drug Code) for Cimzia 200 mg/mL is 50474-710, listed by UCB, Inc..
Other Cimzia Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)